Ceftazidime-avibactam Versus Doripenem for the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis: RECAPTURE, a Phase 3 Randomized Trial Program
Tóm tắt
Từ khóa
Tài liệu tham khảo
Tandogdu, 2014, Resistance patterns of nosocomial urinary tract infections in urology departments: 8-year results of the global prevalence of infections in urology study, World J Urol, 32, 791
Actavis Inc. AVYCAZ (ceftazidime-avibactam) for injection, for intravenous use: prescribing information. Available at: http://pi.actavis.com/data_stream.asp?product_group=1957&p=pi&language=E . Accessed 18 December 2015.
European Medicines Agency. Addendum to the guideline on the evaluation of medicinal products indicated for treatment of bacterial infections. London: EMA, 2013. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2013/11/WC500153953.pdf . Accessed 18 December 2015.
US Food and Drug Administration. Guidance for industry on complicated urinary tract infections: developing drugs for treatment. Draft guidance. Available at: http://www.regulations.gov/contentStreamer?documentId=FDA-2012-D-0148-0002&attachmentNumber=1&disposition=attachment&contentType=pdf . Accessed 18 December 2015.
Clinical Laboratory and Standards Institute. Performance standards for antimicrobial susceptibility testing. 22nd informational supplement: Wayne, PA: CLSI, 2012.
Grabe M , Bartoletti R , Bjerklund Johansen TE et al . Guidelines on urological infections. Available at: http://uroweb.org/wp-content/uploads/19-Urological-infections_LR2.pdf . Accessed 9 November 2015.
Shionogi Inc. DORIBAX (doripenem for injection), for intravenous use: prescribing information. Available at: http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022106s015lbl.pdf . Accessed 18 December 2015.